Cryno is developing a novel GLP-1 agonist for treatment and prevention of peripheral neuropathy and management of type 2 Diabetes and its complications.
| Website | http://cryno.bio/ |
| Revenue | $2 million |
| Employees | View employees |
| Founded | 2016 |
| Technologies |
JavaScript
,
HTML
,
Google Analytics
+3 more
(view full list)
|
| Industry | Biotechnology Research, Manufacturing General, Manufacturing |
| Competitors | Synthesia, Rephrase.ai, Synthesis AI, Pictory, Lumen5, Descript, Runway Academy, InVideo, Animoto, Qure.ai +43 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541711 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies |
Looking for a particular Cryno employee's phone or email?
Cryno Questions
The Cryno annual revenue was $2 million in 2026.
Cryno is based in Moscow, Moscow.
The NAICS codes for Cryno are [541711, 54, 541, 54171, 5417].
The SIC codes for Cryno are [87, 873].
Related Companies
G2Crowd Trusted
300K+
Plugin Users
